Related Experiment Video

Updated: Jun 6, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Waldenström macroglobulinemia: is newer really better?

Morie A Gertz1

  • 1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA. gertz.morie@mayo.edu

Leukemia & Lymphoma
|November 12, 2010
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Related Experiment Videos

Last Updated: Jun 6, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

Articles linked to this work by shared authors, journal, and citation graph.

Advances in the treatment of hereditary transthyretin amyloidosis: A review.

Brain and behavior·2019

The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors.

Acta haematologica·2019

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern.

British journal of haematology·2019

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis.

American journal of hematology·2019

Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis.

Expert review of clinical pharmacology·2019

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis.

American journal of hematology·2019

Multimorbidity patterns and survival outcomes in older adults with multiple myeloma: findings from SEER-Medicare.

Leukemia & lymphoma·2026

Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.

Leukemia & lymphoma·2026

Venetoclax and hypomethylating agents versus other therapies: an international, multicenter, retrospective cohort chart review study.

Leukemia & lymphoma·2026

Real-world analyses of bispecific antibodies and CAR-T cell therapy in relapsed or refractory multiple myeloma: a global TriNetX discovery and contemporary validation cohort.

Leukemia & lymphoma·2026

Multidisciplinary approach to early identification of inborn errors of immunity in patients with lymphoproliferation.

Leukemia & lymphoma·2026

Systematic literature review of clinical outcomes, health-related quality of life, and healthcare costs and resource use in relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel.

Leukemia & lymphoma·2026

Retraction notice to "Rapid cutaneous remission response to tofacitinib and systemic corticosteroids in VEXAS syndrome with a novel UBA1 mutation" [JAAD Case Reports 68 (2026) 105-107].

JAAD case reports·2026

Renal Ewing Sarcoma Mimicking Neuroblastoma: A Multitracer PET/Scintigraphic Imaging Pitfall.

Clinical nuclear medicine·2026

Organoid-based evaluation of SA55 and Pemivibart against evolving SARS-CoV-2 variants.

Emerging microbes & infections·2026

Who owns your doctor? A decade of trends in physician practice ownership in dermatology and gastroenterology.

Health affairs scholar·2026

Systemic Metallosis Mimicking Malignancy on [18F]FDG PET/CT.

Clinical nuclear medicine·2026

The evolving role of the histotechnologist in digital, value based healthcare.

Journal of histotechnology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us